Our findings reveal that HLA‐DR+ tumor cells are not only enriched in HBV+HCC but are also associated with immune checkpoint activation, including PD‐L1 expression, and may contribute to the exhaustion of CD8+ T cells. The gene discussed is CD8A; the disease is hepatocellular carcinoma.